Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 5, 2020, Sutro Biopharma, Inc. (the "Company") held its 2020 Annual Meeting of Stockholders and the following proposals were adopted:







   1.  Election of three Class II directors, identified in the table below, each
       to serve a three-year term, which will expire at the 2023 Annual Meeting of
       Stockholders and until such time as their respective successors have been
       duly elected and qualified or until their earlier resignation or removal:





    Nominees        Shares    Shares    Shares    Broker
                     For     Withheld Abstaining Non-Votes

William J. Newell 15,003,659 826,091 - 846,691 Connie Matsui 14,970,091 859,659 - 846,691 James Panek 15,811,205 18,545 - 846,691










   2.  Ratification of the appointment of Ernst & Young LLP as the Company's
       independent registered public accounting firm for the fiscal year ending
       December 31, 2020:





  Shares   Shares    Shares    Broker
   For     Against Abstaining Non-Votes

16,671,211  5,230      -          -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses